RockstrochJK, SpenglerU. HIV and hepatitis C virus co-infection. Lancet, 2004; 4:437–444.
2.
KimAY, OnofreyS, ChurchDR. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis, 2012; 207:S1–S6.
3.
EACS guidelines Version 5, Clinical Management and Treatment of Chronic Hepatitis B & C.
4.
AdvaniA, ShaharY, MusenM. Medical quality assessment by scoring adherence. J Am Med Inform Assoc, 2002; 9:S92–S97.
5.
AdamsA, SoumeraiS, LomasJ, Ross-DegnanD. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care, 1999; 11:187–192.
6.
HooverKW, ButlerM, WorkowskiKAet al.Evaluation group for adherence to STD and hepatitis screening, low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis, 2012; 39:349–353.
7.
GarveyL, CurtisH, BrookG. The British HIV Association national audit on the management of subjects co-infected with HIV and hepatitis B/C. Int J STD AIDS, 2011; 22:173–176.
8.
WrightTL, YeeH. VA treatment recommendations (version 5.0)Federal Practitioner. Veterans Health Administration, 2003; 20:S1–S33.
9.
FullerB, RodriguezV, LinkeA, HauserP. HIV co-testing among veterans with chronic hepatitis C. Open Infect Dis J, 2011; 5:91–96.
10.
European Centre for Disease Prevention and Control. Hepatitis B and C in the EU neighbourhood: Prevalence, burden of disease and screening policies. Stockholm: ECDC, 2010.
11.
TaylorLE, DeLongAK, MaynardMAet al.Acute hepatitis C virus in an HIV clinic: A screening strategy, risk factors, and perception of fisk. AIDS Patient Care STDs, 2011; 26:571–577.
12.
BonnardP, PialouxG. Evaluation of a computer algorithm for promoting both annual hepatitis C screening and hepatitis B vaccination among HIV-infected individuals (ORCHESTRA) programme. Intl J STD AIDS, 2011; 22:613–616.
